Send us a Message

Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   


The Clinical Measurement Ontology (CMO), Measurement Methods Ontology (MMO), and Experimental Condition Ontology (XCO) are currently being developed at the Rat Genome Database. For more information about these vocabularies please see Shimoyama et al. Three ontologies to define phenotype measurement data. Front Genet. 2012;3:87. Epub 2012 May 28 or contact us (

Term:congenital malformation incidence/prevalence measurement
go back to main search page
Accession:CMO:0002752 term browser browse the term
Definition:Any measurement in which the number of individuals in a study population that display congenital malformation(s) at a point in time or develop congenital malformation(s) within a determined period of time are compared to the total number of individuals in the study population. Often expressed as a percentage but could be expressed as a ratio. Congenital malformations represent a heterogenous group of structural defects, which are usually identified at birth.

show annotations for term's descendants           Sort by:
percentage of study population developing unilateral renal agenesis during a period of time term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Renag1 Renal agenesis QTL 1 IDA RGD PMID:16845468 RGD:1580355 NCBI chr14:8,170,668...68,298,175 JBrowse link

Term paths to the root
Path 1
Term Annotations click to browse term
  clinical measurement 2369
    disease population measurement 57
      disease incidence/prevalence measurement 57
        congenital malformation incidence/prevalence measurement 1
          anorectal malformation incidence/prevalence measurement + 0
          renal agenesis incidence/prevalence measurement + 1
paths to the root